STACY POWELL: Open Payments
NPI 1144704875 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 19 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $39 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| BeOne Medicines USA, Inc. | 3 | $62 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Genentech USA, Inc. | 1 | $27 |
| PharmaEssentia USA Corporation | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Kite Pharma, Inc. | 1 | $19 |
Products named: KEYTRUDA, BRUKINSA, LIBTAYO, CALQUENCE, SCEMBLIX, Venclexta, BESREMI, Enhertu.
Industry payments across AL — which companies pay providers there.
